ATLASCharles River Laboratories International (CRL) earnings date: Nov 4, 2026
Charles River Laboratories International (CRL) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, before the open. Analysts expect EPS of $2.98.
Source: company filings and exchange data · Updated Nov 2, 2026
Charles River Laboratories International reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Charles River Laboratories International. You can switch it off at any time.
Alert me before CRL reportsFree to start. Creating an account takes under a minute.
CRL earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $2.98 |
| Last report | Aug 5, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -25.4% |
| Average move around a report | ±5.0% (last 5) |
| Sector | Healthcare · Diagnostics & Research |
Charles River Laboratories International earnings history: last 5 reports
Charles River Laboratories International last reported on Aug 5, 2026: EPS of $3.02 against an estimate of $2.74 (+10.2% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | $2.74 | $3.02 | +10.2% | Beat | +13.4% |
| Jul 9, 2026 | $0.04 | -$0.02 | -150.0% | Miss | +4.2% |
| May 7, 2026 | $1.95 | $2.06 | +5.6% | Beat | -2.3% |
| Feb 18, 2026 | $2.35 | $2.39 | +1.7% | In line | +3.6% |
| Jan 15, 2026 | $2.98 | $3.14 | +5.4% | Beat | +1.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
ATLAS view on CRL before the report
| Last price | $359.41 (-4.4%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 49% |
| Likely 1-month range (50%) | $329.87 – $388.76 |
| Normal 1-day range (±1σ) | ±2.8% |
These figures come from the same calibrated model and valuation as the Charles River Laboratories International stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get the full ATLAS analysis for CRL
See the fair value, the probability range and the earnings history of Charles River Laboratories International on its ATLAS page.
Charles River Laboratories International (CRL) stock analysisPlans from €3.99 a month.
Charles River Laboratories International earnings: frequently asked questions
When does Charles River Laboratories International (CRL) report earnings?
Charles River Laboratories International is scheduled to report on Wednesday, November 4, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CRL?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $2.98 per share (USD). Estimates can change before the report.
How often does CRL beat earnings estimates?
Of its last 5 reports with a recorded result, Charles River Laboratories International beat the EPS estimate 3 times; the average surprise was -25.4%. Past results do not predict the next one.
How much does CRL move around earnings?
Over its last 5 reports the stock moved an average of 5.0% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Charles River Laboratories International beat earnings estimates last quarter?
Charles River Laboratories International last reported on Aug 5, 2026: EPS of $3.02 against an estimate of $2.74 (+10.2% surprise), a beat.
How much does CRL usually move in a day?
On a normal trading day the ATLAS model puts CRL’s one-day range at about ±2.8%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer